ライフサイエンスコーパス: transporter

1 ncodes a major facilitator superfamily (MFS) transporter.

2 x interacted more efficiently with the YecSC transporter.

3 ATPase that represents a candidate polyamine transporter.

4 envelope and functioned as a low-affinity Pi transporter.

5 substrates that are translocated by the MmpL transporter.

6 ated with down-regulation of the host SLC7A2 transporter.

7 addition, GltS was identified as a glutamate transporter.

8 ty of dedicated cholesterol and phospholipid transporters.

9 elices 1, 6, and 10 and conserved among SLC7 transporters.

10 esign based on knockout metabolomics of drug transporters.

11 and translocation by WzmWzt and related ABC transporters.

12 neurons express vesicular glutamate or GABA transporters.

13 repressing the transcription of zinc uptake transporters.

14 specific to voltage-gated transmembrane ion transporters.

15 e-forming proteins, such as porins and ionic transporters.

16 not reduce the transport rate of individual transporters.

17 the 'credit card swipe' model of other lipid transporters.

18 utionary origins of widespread Na(+)-coupled transporters.

19 logies within the KDELR-family of retrograde transporters.

20 achieved through the function of SUT sucrose transporters.

21 d explaining the number and diversity of ABC transporters.

22 yeast mitochondria lacking endogenous NAD(+) transporters.

23 tein family 0016), a family of secondary ion transporters.

24 involve presynaptic component vesicular GABA transporters.

25 plasms identified rice Lysine-Histidine-type Transporter 1 (OsLHT1) as a candidate gene associated wi

26 inase 1 (TK-1), and equilibrative nucleoside transporter 1 (SLC29A1) in HCC compared with liver tissu

27 and that pharmacologic inhibition of glucose transporter 1 and PRC1 synergistically promoted ER stres

28 nistically, glucose uptake via GLUT (glucose transporter)-1 and enhanced glycolysis in neutrophils pr

29 evious expression of the vesicular glutamate transporter 2 (Vglut2) gene, coupled with immunofluoresc

30 P neurons expressing the vesicular glutamate transporter 2 (VP(VGluT2))], whose activation generates

31 owering blood sugar by the sodium-glucose co-transporter 2 inhibitor empagliflozin provides cardiac p

32 Stress-responsive genes such as proline transporter 2, NADP-dependent glyceraldehyde and superox

33 s, despite dual inhibition of sodium-glucose transporter-2 and the renin-angiotensin system, remains

34 Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoac

35 de-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type

36 is composed of transient vesicular glutamate transporter 3 (tVGLUT3) neurons, which convey primarily

37 o be required for insulin-stimulated glucose transporter 4 translocation in mouse skeletal muscle.

38 ells in vitro, reducing the abundance of ABC transporter A1 (ABCA1) and thus cholesterol efflux and i

39 An efflux transporter, ABCG2, was lower, while mRNAs encoding VE-c

40 Alterations in transporter activities were further suggested by media a

41 th reduced placental glutamine and glutamate transporter activity and expression, and propose the mam

42 diated histidine uptake, system L amino acid transporter activity and Na(+) K(+) -ATPase activity usi

43 mprehensive MRI technique for mapping biotin transporter activity in the murine placenta.

44 The role of CCC1 ion transporter activity in the regulation of plant immunity

45 uggest that abnormal glutamine and glutamate transporter activity is part of the spectrum of placenta

46 into three classes and, though the regulated transporter activity of class I proteins is becoming bet

47 Our results clarify the transporter activity of essential eukaryotic RND protein

48 Here, we find that inhibition of ABC transporter activity reduces migration of GSCs towards l

49 ted histidine uptake and system L amino acid transporter activity were similar in sarcolemmal membran

50 importance of key coordinating residues for transporter activity, and provide a structural explanati

51 CdiB transporters adopt a TpsB fold, containing a 16-stranded

52 tercellular communication, and transmembrane transporters, all of which are precursors for impaired g

53 and C-terminal halves in many eukaryotic ABC transporters, allowing all four consensus functional dom

54 The ammonium transporter (AMT)/methylammonium permease (MEP)/Rhesus g

55 EAAT5 acts as a slow glutamate transporter and also as glutamate-gated chloride channel

56 usal relationship between amygdala serotonin transporter and an animal's sensitivity to threat by rev

57 bundle protein that acts as an intracellular transporter and buffer for fatty-acyl-CoA and is active

58 lowly than the constitutively secreted GLUT1 transporter and localize CHC22 to the ER-to-Golgi interm

59 he CD147-Ig1 domain, displaces CAIX from the transporter and suppresses CAIX-mediated facilitation of

60 e induced by ligand binding to the serotonin transporter and to the glycine transporters (GlyT1 and G

61 se compounds were in vitro substrates of the transporter and validated the differences observed betwe

62 unction as coupled glutamate/Na(+)/H(+)/K(+) transporters and as anion-selective channels.

63 O, there was significant dysregulation of BA transporters and BA detoxification/synthesis enzymes in

64 ved in cellular transport, including calcium transporters and cytoskeletal regulators, that are assoc

65 Sulfate transporters and genes involved in sulfate and Met metab

66 Deepened eisosomes are able to trap nutrient transporters and protect them from rapid endocytosis.

67 sis, genes encoding ferritin, flavodoxin, Fe transporters and siderophore uptake genes were more abun

68 LTP-triggered PAP withdrawal involves NKCC1 transporters and the actin-controlling protein cofilin b

69 e global structural similarity of homologous transporters and the enormous diversity of their substra

70 ly needed to understand these novel membrane transporters and their contributions to health and disea

71 ide insight into the assembly of PACE family transporters and their regulation via LTTR proteins on d

72 chitecture of several medically relevant ABC transporters and their supramolecular assemblies, includ

73 attributed to disruption of one of two d-Ser transporters and/or activation of a previously nonfuncti

74 he two CRM1 similarly, NESs from Mek1, eIF4E-transporter, and RPS2 showed >10-fold affinity differenc

75 tivating enzymes, ATP binding cassette (ABC) transporters, and central carbon metabolic proteins) wer

76 aE, has minimal sequence similarity to other transporters, and the structure of the entire inner-memb

77 By limiting spillover, glutamate transporters are believed to prevent excessive activatio

78 r iron, and questions remain regarding which transporters are involved.

79 Ion transporters are key players of cellular processes.

80 These transporters are not saturated with glutamine in vivo an

81 These findings identify ABCC4 transporter as a new target in SHH-MB, prompting the dev

82 synaptic dopamine autoreceptors and dopamine transporters-as well as heterosynaptic mechanisms, such

83 is caused by variation in type and number of transporters, assimilation machinery, and anatomical fea

84 ansporter TmrAB, a functional homolog of the transporter associated with antigen processing (TAP) by

85 mplex, a scaffold for signaling proteins and transporters at the cell membrane; MLXIP that, with the

86 revealed that specific localization of auxin transporters at the different membranes of these young c

87 ycogen synthase (glys), atp-binding cassette transporter (atp), and low-density lipoprotein receptor

88 cently revealed that the late endo-lysosomal transporter ATP13A2 pumps polyamines like spermine into

89 Pathogenic mutations in the copper transporter ATP7B have been hypothesized to affect its p

90 lular auxin receptor - rather than the auxin transporter AUXIN RESISTANT 1 (AUX1) - was considered to

91 ch include tracers of bacterial maltodextrin transporter, bacterial thymidine kinase, antibiotics, an

92 RS) working in a sensory complex with an ABC-transporter (BceAB), together acting as a flux-sensor wh

93 Although both of these transporters belong to the ABC family and mediate the ef

94 is a prototypical H(+) -dependent multidrug transporter belonging to the Major Facilitator Superfami

95 tition between two carbon sources for shared transporters, between transcription factors for binding

96 n MGAS5005, the annotated beta-glucoside PTS transporter (bglP) was found to be crucial for GAS growt

97 terest in using endogenous compounds as drug transporter biomarkers to facilitate drug-drug interacti

98 mpts spatial retreat of astroglial glutamate transporters, boosting glutamate spillover and NMDA-rece

99 ikely compensated for by the related SLC20A1 transporter, but strongly decreased XPR1-mediated phosph

100 native function of Esbp6 revealed that this transporter can excrete fusel acids (byproducts of aroma

101 Determining drug interactions with these transporters can be useful in identifying and predicting

102 Multidrug transporters can confer drug resistance on cells by extr

103 se findings identify SLC25A51 as a mammalian transporter capable of importing NAD(+) into mitochondri

104 bly affect transport rates of NBCe1 or other transporters carrying HCO3- , CO3= , or NaCO3- ion pairs

105 5 (SLC7A5) gene, which encodes an amino acid transporter cause microcephaly and seizures, yet the mec

106 ATP-binding cassette (ABC) transporters chemomechanically couple ATP binding and hy

107 ATP-binding cassette (ABC) transporters constitute one of the largest and most anci

108 ABC-transporter copy number, expression and activity were ex

109 ity was unsurprising, disruption of a single transporter, CycA, was sufficient to completely overcome

110 utations in CTNS-a gene encoding the cystine transporter cystinosin-cause the rare, autosomal, recess

111 orphisms reducing expression of the dopamine transporter (DAT) are associated with some conditions.

112 dopamine D(2/3) receptor (D2/3R) or dopamine transporter (DAT) availabilities, or synaptic dopamine l

113 Atypical dopamine transporter (DAT) inhibitors have shown therapeutic pote

114 ined by its capacity to inhibit the dopamine transporter (DAT), and emerging evidence suggests that d

115 gainst tyrosine hydroxylase (TH) or dopamine transporter (DAT).

116 r magnesium and that down-regulation of this transporter decreases glucose-stimulated insulin secreti

117 Riboflavin transporter deficiencies (RTDs), involving SLC52A3 and S

118 rve choline and phosphatidylcholine, choline transporter deficiency was implicated in impaired membra

119 set neurometabolic disease caused by choline transporter deficiency with autosomal recessive inherita

120 nce of this transport system was verified in transporter-deficient rats as a secondary model organism

121 MB-231 breast cancer cells, the cell-surface transporter density (n) may decay with cell radius (r) f

122 sed of a guanylyl cyclase and a phospholipid transporter domain.

123 main insertion, by expressing the individual transporter domains cell-free.

124 l themes including up-regulation of nutrient transporters, down-regulation of adhesion molecules and

125 odegenerative diseases, the contributions of transporter dysfunction to disease pathophysiology remai

126 hat, although CAs could stimulate non- HCO3- transporters (e.g. Na-H exchangers) by accelerating CO(2

127 ghtly controlled by the astrocytic glutamate transporter EAAT2, influencing synaptic functioning and

128 Excitatory amino acid transporters (EAATs) are prototypical dual function prot

129 g interactions with equilibrative nucleoside transporter (ENT) 1 and ENT2 using Bayesian modeling.

130 JNK, inhibits expression of the gemcitabine transporter ENT1, so that cells take up smaller amounts

131 NK), inhibited expression of the gemcitabine transporter ENT1, which reduced gemcitabine uptake by pa

132 Equilibrative nucleoside transporters (ENTs) 1 and 2 facilitate nucleoside transp

133 How do ABC transporters evolve to carry such diverse molecules and

134 While glutamate transporter expression is reduced in numerous neurodegen

135 any of the targeted brain regions, serotonin transporter expression, specifically within the right ve

136 Several missense mutations in the orphan transporter FLVCR2 have been reported in Fowler syndrome

137 in receptor (TfR), a native receptor and BBB transporter for the iron chaperone transferrin.

138 Here, we co-reconstituted ECF transporters for folate (ECF-FolT2) and pantothenate (EC

139 carnosine compared to previously identified transporters for these ligands.

140 azoans and utilizes a wide array of nutrient transporters found on the absorptive enterocytes of the

141 We show that two transporters from the ubiquitous Major Facilitator Super

142 istribution across H4c domain controls slc13 transporter function and is utilized by slc13-interactin

143 e also developed a robust assay of serotonin transporter function and modulation by drugs.

144 Here, we show that blocking GABA transporters (GATs) in acute rat brain slices containing

145 be determined by plasma membrane GABA uptake transporters (GATs) located on astrocytes and neurons.

146 on protein between LPL and its physiological transporter GBIHBP1 that is highly active and largely re

147 n emotion regulation revealed that serotonin transporter gene expression in the ventrolateral prefron

148 Machine learning models using transporter gene frequencies were predictive of known si

149 y increasing the transcript level of silicon transporter genes (EcLsi1, EcLsi2 and EcLsi6) as well as

150 Transporter genes associated with BGCs were often equall

151 ts show that consideration of BGC-associated transporter genes can inform predictions of specialized

152 e present study, we identified three silicon transporter genes viz.

153 oot anatomy, up-regulation of Si channel and transporter genes, ascorbate-glutathione cycle and nutri

154 he expression of mitochondrial influx Ca(2+) transporter genes, but upregulation in the genes related

155 ated the expression of Si channel and efflux transporter genes- Lsi1 and Lsi2 while the addition of S

156 assessed surface expression of the glutamate transporter GLT-1 and glutamate efflux in the nucleus ac

157 c factors, BDNF and IGF-1, and the glutamate transporter, GLT-1 after ischemic brain damage.

158 .026) placental mRNA expression of a glucose transporter (GLUT-3) and increased (P = 0.037) placental

159 eletion of only one highly expressed glucose transporter, Glut1 or Glut3, in cancer cells does not im

160 Glycogen and glucose transporter GLUT4 are decreased.

161 the cellular membrane by a family of glucose transporters (GLUTs).

162 the serotonin transporter and to the glycine transporters (GlyT1 and GlyT2).

163 or both flagellar trafficking of the glucose transporter GT1 and for successful cytokinesis and survi

164 ein (Rh) family of ammonia (NH(3)/NH(4) (+)) transporters has been identified in organisms from all d

165 Why do some ABC transporters have connectors and others not?

166 Other SLC transporters have emerged as pharmacology targets.

167 r from previous observations for similar ABC transporters, highlighting the extent of mechanistic div

168 ence imaging of the archaeal model glutamate transporter homologue Glt(Ph) from Pyrococcus horikoshii

169 in vivo functionality of the chlamydial Opp transporter in C. trachomatis Importantly, we found that

170 gene encoding an ATP-binding cassette (ABC) transporter in PEL-negative individuals.

171 Slc39a14) was the most highly expressed zinc transporter in skeletal muscle of mice in response to LP

172 a membrane localization of the GLUT4 glucose transporter in skeletal muscle, but are not deficient in

173 e will discuss the role played by nucleoside transporters in human health and disease, with emphasis

174 macrophages have focused on the role of ABC transporters in moving cholesterol onto high-density lip

175 Finally, LRRC8A channels are key cGAMP transporters in resting primary human vasculature cells

176 he involvement of these mitochondrial Ca(2+) transporters in supporting the CRAC current (I(CRAC) ) u

177 cose lowering properties by inhibiting sugar transporters in the small intestine and improving insuli

178 entified in other CAX homologs and/or Ca(2+) transporters, including the mammalian Na(+)/Ca(2+) excha

179 lar cholesterol levels mediated by the ABCG1 transporter increase ATP release by volume-regulated ani

180 gh levels of the membrane transporter, using transporter inhibition assays and transient knockdown of

181 te commonly used in high-throughput in vitro transporter inhibition assays in the early ADME profilin

182 tion and provide the first example of an ECF-transporter involved in overcoming host-induced nutritio

183 nputs to regulate different ion channels and transporters involved in the control of K(+) fluxes by p

184 cytoplasm by the ATP binding cassette (ABC) transporter IrtAB(4), which features an additional cytop

185 In humans, the most abundant OMM transporter is the voltage-dependent anion channel.

186 the expression of lipid-binding proteins and transporters is increased(8).

187 nderstanding of substrate selectivity by SMR transporters is needed to identify the types of selectiv

188 T (SLC13A5; mINDY), a sodium-coupled citrate transporter, is the mammalian ortholog of Drosophila IND

189 expression of GABA(A)R or of the chloride co-transporter KCC2, but rather with inhibition of KCC2 dim

190 olvement in the regulation of ATPase, cation transporter, kinase and UDP-glycosyltransferases genes.

191 sed expression of the alternative amino acid transporters LAT2 and LAT3.

192 The purine nucleobase transporter LdNT3 is among the most substantially up-reg

193 this process, and mutations in these sterol transporters lead to disorders such as Tangier disease a

194 o an increase in insulin-independent glucose transporter levels, enhanced cellular glucose uptake, hi

195 Dichloropane, a monoamine transporter ligand, enables targeting of dense dopaminer

196 this system, the ATP-binding cassette (ABC) transporter LptB(2) FGC extracts LPS from the inner memb

197 Proton-coupled monocarboxylate transporters MCT1-4 catalyze the transmembrane movement

198 is due to acid inhibition of monocarboxylate transporters (MCTs), resulting in a negative feedback on

199 tons, which are exported via monocarboxylate transporters (MCTs), supporting the formation of an acid

200 Similar to other transporters, MdfA purportedly functions by alternating

201 al change - which occurs in all conventional transporter mechanisms - has not been observed in any hi

202 The solute carrier family 13 (slc13) transporters mediate transport of the metabolites succin

203 Amino acid transporter-mediated histidine uptake and system L amino

204 We developed a novel protocol to measure transporter-mediated histidine uptake, system L amino ac

205 nities to transpass the BBB/BBTB via glucose-transporter-mediated transcytosis by MA.

206 compounds, which are oftentimes subjected to transporter-mediated uptake, are challenging in drug dis

207 confirmed that (i) genes encoding methionine transporter (metP) and manganese transporter (mtsA) are

208 methionine transporter (metP) and manganese transporter (mtsA) are crucial for GBS survival in whole

209 d-linked cell wall monomer, Lipid II, by its transporter MurJ.

210 he expression of the plasma membrane citrate transporter NaCT in HepG2 cells and decreases cellular l

211 role is shared with at least one additional transporter native to S. cerevisiae (Pdr12).

212 the human SLC4A7 gene encoding the Na/HCO(3) transporter NBCn1 suggest that this pH-regulating protei

213 d heme transport system containing near-iron transporter (NEAT) domains and its efficacy as a vaccine

214 Consistent with eIF4E-transporter NES binding weaker to CRM1(E571K), eIF4E-tra

215 ends on the regulated expression of chloride transporters NKCC1 and KCC2.

216 ab) immunized against a bacterial 14TM helix transporter, NorC, from Staphylococcus aureus We identif

217 The multispecific organic anion transporters, OAT1 (SLC22A6) and OAT3 (SLC22A8), the mai

218 MhsT of Bacillus halodurans is a transporter of hydrophobic amino acids and a homologue o

219 We recently identified MmpL11 as a conserved transporter of mycolic acid-containing lipids including

220 that increase the expression of cholesterol transporters on atheroma macrophages leading to increase

221 alizations between pSTAT5 and vesicular GABA transporter or vasopressin were observed, whereas approx

222 signaling pathways, surface markers, efflux transporters, or components of complex tumor microenviro

223 robe substrate to assess the activity of the transporter P-glycoprotein (P-gp) in humans.

224 membrane permeability, and is not an efflux transporter (P-gp) substrate.

225 pression of GLUT4, the high capacity glucose transporter, partially rescues viral replication in the

226 vered and validated the plasmodial l-lactate transporter, PfFNT, as a novel antimalarial drug target.

227 ATP-binding cassette (ABC) transporters play several critical roles in this process

228 nstrated that knockdown of XPR1, a phosphate transporter present in MIN6m9 cells and pancreatic islet

229 Multidrug transporters prompt multidrug resistance by exporting di

230 ere, we report the black flying fox receptor transporter protein 4 (RTP4) as a potent interferon (IFN

231 = 1.1 x 10-14), the SLC19A1/(ABCC1 + ABCC4) transporter ratio (P = 3.6 x 10-4), the MTX infusion tim

232 al biomarkers for OCT1 and additional cation transporters (renal OCT2, MATE1, and MATE2K).

233 otential application as long-range molecular transporters, responsive surfaces, and (bio)sensors.

234 We further show that inhibitors of glucose transporters selectively kill SLC7A11(high) cancer cells

235 In addition, serotonin transporter (SERT) expression was upregulated in both DR

236 D(2)/D(3), 5-HT(1A), 5-HT(2A) and serotonin transporter (SERT) occupancies of brexpiprazole in adult

237 bound at the dimer interface in the leucine transporter show decreased k(off) rates in molecular dyn

238 Dopamine transporter single-photon emission computed tomography c

239 d mRNA-seq analysis identified the glutamine transporter SLC1A5 as an FTO target that promotes metabo

240 he intracellular uptake of sUA via the urate transporter SLC2A9/GLUT9.

241 GWAS is a missense mutation in the manganese transporter SLC39A8, which is associated with altered gl

242 by expressing high levels of the methionine transporter SLC43A2.

243 derophores as pathogenicity factors, we used transporters specific for siderophore BGCs to identify b

244 learned, and new opportunities to illuminate transporter structure and function.

245 are often protected from treatment by efflux transporters, such as P-glycoprotein (P-gp) at the blood

246 a regulatory mechanism for the Ca(2+)/cation transporter superfamily.

247 They include genes encoding transporters, surface proteins, transcriptional regulato

248 lacentas with reduced activity of amino acid transporter systems A and L, thought to contribute to po

249 e was identified that is a NRT2-type nitrate transporter TaNRT2.5 with a key role in seed vigour.

250 ause p53 regulates expression of the peptide transporter Tap1 and the aminopeptidase Erap1, which are

251 t, orally bioavailable inhibitors of glucose transporters, targeting both GLUT1 and GLUT3.

252 opsis root epidermal cells requires the IRT1 transporter that also allows the entry of certain non-ir

253 R1 and STK39 kinases, and the SLC12A2 ion co-transporter that are required for post-transcriptional u

254 ABCB4 is an ATP-binding cassette transporter that extrudes phosphatidylcholine into the b

255 s as a chloroplast-localized low-affinity Pi transporter that mediates UV tolerance and rice yields a

256 FtsEX is a bacterial ABC transporter that regulates the activity of periplasmic p

257 ort is mediated by the ubiquitous Amt/Mep/Rh transporters that includes the human Rhesus factors.

258 A plasma membrane transporter, the solute carrier (SLC) human multidrug an

259 ecular identification of vesicular glutamate transporter three and cholecystokinin expressing cortica

260 istic understanding of the heterodimeric ABC transporter TmrAB, a functional homolog of the transport

261 l binding and facilitate return of the empty transporter to an outward-open state upon metal release.

262 ggest that Chlamydia evolved an oligopeptide transporter to facilitate the acquisition of oligopeptid

263 d its putative ligand-binding sites face the transporter to likely modulate ATPase activity upon O an

264 via trafficking to the vacuole, heterologous transporters to facilitate intracellular routing, and st

265 nterfaced with biological systems can act as transporters to move cargo such as hydrogel alginate cap

266 Therefore, targeting glucose transporters to regulate aerobic glycolysis is an attrac

267 tic resistance and detoxification, including transporters, transpeptidases, and thioredoxins.

268 e use tripartite ATP-independent periplasmic transporters (TRAPs) to scavenge sialic acid from host t

269 Next, we show that the iron transporter Tsf1 is induced by infections downstream of

270 encode a putative tripartite tricarboxylate transporter (TTT).

271 h high xCT expression and identified glucose transporter type 1 (GLUT1).

272 PA increased the amount of glucose transporter type 1-positive cerebral blood vessels, reve

273 proposed to function in delivery of glucose transporter type 4 (GLUT4)-containing vesicles to the pl

274 ABC transporters undergo substantial conformational changes

275 ltidrug resistance protein 1 (MDR1) membrane transporter up-regulation in both the mouse astrocytes a

276 we review recent studies of diverse membrane transporters using computational methods, with an emphas

277 which expresses high levels of the membrane transporter, using transporter inhibition assays and tra

278 served that both systems, the sensor and the transporter, utilize galactose-binding proteins that als

279 r cholinergic marker vesicular acetylcholine transporter (VAChT).

280 neurons that express ESR1 and vesicular GABA transporter (VGAT) (MPOA(ESR1 VGAT) neurons) robustly pr

281 ing the vesicular glutamate (vGLUT2) or GABA transporter (vGAT), then determined whether TH-ir neuron

282 annelrhodopsin-(ChR2)-EYFP in vesicular GABA transporter (VGAT)-expressing neurons.

283 chinery mediated through vesicular glutamate transporters (VGLUTs) that ultimately dictate glutamater

284 ter NES binding weaker to CRM1(E571K), eIF4E-transporter was mislocalized in tumor cells carrying CRM

285 A strain lacking these three transporters was able to tolerate 100 mM serine whereas

286 ition, Slc30a10, encoding a manganese efflux transporter, was one of the genes most induced by 1,25(O

287 Focusing on a group of ABCG transporters, we propose that exaptation by regulatory d

288 vasculature cells and universal human cGAMP transporters when activated.

289 s that support the normal functioning of the transporter, when reconstituted in vesicles of defined l

290 embrane stress pathways and release nutrient transporters, which aids in their down-regulation.

291 al information on ATP binding cassette (ABC) transporters, which are expressed in the human liver.

292 rmal proximal tubules through P-glycoprotein transporter while being retained in cancerous kidney tis

293 , we summarize the RND superfamily of efflux transporters with a primary focus on the assembly and fu

294 Pre-saturation of the transporters with free biotin suppressed b-BSA-Gd-DTPA u

295 ive transcript abundance patterns of various transporters with known functions in salinity tolerance.

296 The association of the two transporters with the same disease suggests that they jo

297 different GPCRs, ion channels, receptors and transporters without disrupting their structure.

298 on and subsequent loading onto the dedicated transporter Wntless/evenness interrupted (WLS/Evi).

299 ded on YjhC and on the predicted sialic acid transporter YjhB.

300 The zinc transporter ZIP9 (SLC39A9) was recently characterized as